CHLA-EP

CHLA-EP, or the Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes, is a dedicated public institution in Uruguay focused on combating major health issues such as tuberculosis and leprosy. As the leading body for the National Program for Tuberculosis Control (PNC-TB) and the Hansen's Disease Post-Elimination Program, CHLA-EP plays a vital role in public health. The organization also oversees the National Vaccination Program (PNV), ensuring effective immunization strategies against various diseases, including COVID-19 and the recently added Respiratory Syncytial Virus (VRS).

CHLA-EP provides a range of services, including vaccination clinics, neonatal screening programs, and public health information dissemination. They also facilitate ongoing training for healthcare professionals and support patients requiring medication through an organized laboratory system. Their commitment extends to community outreach initiatives, aiming to raise awareness and educate the public about critical health issues. With a central mission to improve health outcomes, CHLA-EP exemplifies leadership in public health in Uruguay.